AllianceBernstein’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$590K Hold
190,220
﹤0.01% 2553
2025
Q4
$590K Buy
190,220
+91,540
+93% +$261K ﹤0.01% 2572
2025
Q3
$260K Buy
98,680
+72,260
+274% +$159K ﹤0.01% 2990
2025
Q2
$32.5K Buy
+26,420
New +$28.8K ﹤0.01% 3219
2023
Q4
Sell
-148,270
Closed -$123K 3190
2023
Q3
$123K Hold
148,270
﹤0.01% 3038
2023
Q2
$178K Sell
148,270
-60,800
-29% -$75.7K ﹤0.01% 3009
2023
Q1
$263K Sell
209,070
-900
-0.4% -$1.72K ﹤0.01% 2819
2022
Q4
$456K Hold
209,970
﹤0.01% 2679
2022
Q3
$2.52M Buy
209,970
+160,170
+322% +$1.99M ﹤0.01% 1738
2022
Q2
$417K Hold
49,800
﹤0.01% 2752
2022
Q1
$432K Buy
49,800
+100
+0.2% +$964 ﹤0.01% 2738
2021
Q4
$562K Hold
49,700
﹤0.01% 2681
2021
Q3
$625K Sell
49,700
-5,600
-10% -$51.6K ﹤0.01% 2671
2021
Q2
$449K Sell
55,300
-81,322
-60% -$705K ﹤0.01% 2856
2021
Q1
$1.26M Sell
136,622
-7,700
-5% -$77.6K ﹤0.01% 2312
2020
Q4
$1.4M Sell
144,322
-2,163,992
-94% -$21.3M ﹤0.01% 2163
2020
Q3
$28.6M Buy
2,308,314
+99,884
+5% +$1.32M 0.02% 693
2020
Q2
$28.7M Buy
2,208,430
+372,055
+20% +$4.68M 0.02% 657
2020
Q1
$18.6M Buy
1,836,375
+95,370
+5% +$1.25M 0.01% 707
2019
Q4
$27.2M Sell
1,741,005
-90,441
-5% -$1.82M 0.02% 716
2019
Q3
$30.8M Buy
1,831,446
+210,127
+13% +$4.18M 0.02% 658
2019
Q2
$36M Buy
1,621,319
+228,378
+16% +$4.37M 0.02% 633
2019
Q1
$30.2M Buy
+1,392,941
New +$29M 0.02% 683

Other funds holding GOSS

AllianceBernstein's GOSS Position: Q1 2026 in Review

AllianceBernstein held its Gossamer Bio (GOSS) position steady in Q1 2026 at 190,220 shares worth $590K. The position accounts for ﹤0.01% of the portfolio, ranked #2553.

AllianceBernstein first reported a position in GOSS in Q1 2019 and has held it in 23 quarters since. The position peaked at $36M in Q2 2019. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • AllianceBernstein held 190,220 shares of Gossamer Bio worth $590K as of Q1 2026.
  • AllianceBernstein left its Gossamer Bio share count unchanged in Q1 2026.
  • Gossamer Bio made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2553 holding.
  • AllianceBernstein first reported a position in Gossamer Bio in Q1 2019 and has held it in 23 quarters since.
  • AllianceBernstein's Gossamer Bio position peaked at $36M in Q2 2019.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.